Navigation Links
MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
Date:10/4/2007

rward to working with Siemens Medical Solutions Diagnostics to provide customers with a comprehensive range of solutions to meet the needs of laboratories today and tomorrow."

About MedAssets Inc.

MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, including 2,500 hospitals and 30,000 non-acute care healthcare providers. For more information, go to http://www.medassets.com.

About Siemens Medical Solutions Diagnostics

Siemens Medical Solutions Diagnostics offers a broad portfolio of performance-driven diagnostic solutions that assist in the diagnosis, monitoring and management of disease. Products and services bring together the right balance of science, technology, and practicality across the healthcare continuum to empower medical professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe. Visit http://www.siemens.com/diagnostics.

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area o
'/>"/>

SOURCE Siemens Medical Solutions Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Childrens engages MedAssets for supply chain management
2. A Versatile Power Supply for All Electrophoresis Applications
3. RedPrairie Corp. introduces new supply chain software
4. Probe into gas gouging may educate Americans about pressures on oil supply
5. RedPrarie to provide Polaris with supply chain tech
6. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
7. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
8. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
9. Performance Comparisons of Commercial RT-PCR Systems
10. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
11. In Vivo Signal Transduction Pathway Reporting Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)IRVINE, Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused on changing the world,s transportation fuel paradigm through the production of ethanol from non-food
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
...ewswire-FirstCall/ - SemBioSys Genetics Inc.,(TSX:...io of therapeutic,proteins for metabolic and cardi...gible to proceed with its planned Phase I/II human... the 30-day review period of its,Investigational N...bmitted,the application in July to the U.S. Food a...
...ins momentum with launch of a Phase ...LE, Md., Sept. 16 Novavax, Inc.,(Nasdaq: NVAX ) ...in a Phase,II clinical trial of its virus-like par...Phase IIa randomized, placebo controlled clinical ...of different doses of its seasonal,influenza VLP v...
...l/ - MIGENIX Inc. (the,"Company" or "MIGENIX") (TS... drugs for infectious diseases, reports financial ...nd provides a corporate update on its programs,and...AMS, Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226;...related infections): Cadence Pharmaceuticals, Inc....
Other Biology Technology:SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND 2SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND 3Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 2Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 3Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 4Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 5MIGENIX Reports First Quarter Fiscal 2009 Financial Results 2MIGENIX Reports First Quarter Fiscal 2009 Financial Results 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 4MIGENIX Reports First Quarter Fiscal 2009 Financial Results 5MIGENIX Reports First Quarter Fiscal 2009 Financial Results 6MIGENIX Reports First Quarter Fiscal 2009 Financial Results 7MIGENIX Reports First Quarter Fiscal 2009 Financial Results 8MIGENIX Reports First Quarter Fiscal 2009 Financial Results 9MIGENIX Reports First Quarter Fiscal 2009 Financial Results 10MIGENIX Reports First Quarter Fiscal 2009 Financial Results 11
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):How nutrition affects healthy aging 2New therapy targets for amyloid disease 2Papillomavirus silences innate immune response 2Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 1Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 2Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 3Traumatic brain injury caused by exposure to explosive blast presents critical challenge 49434 1Traumatic brain injury caused by exposure to explosive blast presents critical challenge 49434 2Antibiotics take toll on beneficial microbes in gut 8909 1Antibiotics take toll on beneficial microbes in gut 8909 2Antibiotics take toll on beneficial microbes in gut 8909 3
... PLAIN, N.Y., JULY 27, 2008 In a new March of Dim...tentially deadly disorder that affects about 5 per...s in mice that may have important implications for....D., Ph.D., and Rodney E. Kellems, Ph.D., Departme...n M. Ramin, M.D., Department of Obstetrics, Gyneco...
...MINGHAM, Ala. The life expectancy for patients wi...d by more than 13 years since the late 1990s thank...ding to researchers at the University of Alabama a...Vancouver, British Columbia. , Improved survival ... among 43,355 HIV-positive study participants in E...
...GO (July 25, 2008) New research published in the ... of Surgeons shows elevated plasma DNA is a relia...dy also suggests that plasma DNA levels rise befor...jority of patients. , Esophageal cancer, one of...usually diagnosed at a late stage. An accurate mar...
Other Biology News:New research on pre-eclampsia in mice may have important implications for humans 2Anti-HIV therapy boosts life expectancy more than 13 years 2Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-Raf1 Polyclonal Antibody, Unconjugated from Abcam
Sheep Anti-Human hCG beta core fragment Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-SIT Monoclonal Antibody, Unconjugated, Clone SIT-01 from Abcam
Biology Products: